AstraZeneca, Ranbaxy Can't Ax Claims In Nexium Antitrust MDL
A Massachusetts federal judge on Wednesday rejected AstraZeneca PLC and Ranbaxy Inc.'s bid to dismiss as time-barred certain claims in multidistrict litigation alleging the companies violated antitrust laws by agreeing to...To view the full article, register now.
Already a subscriber? Click here to view full article